Keyphrases
Histamine
100%
Multiple Sclerosis
100%
Nervous System Diseases
100%
Immune-mediated Inflammatory Diseases
100%
H4 Receptor
100%
Disease-modifying Therapy
50%
Disease Course
50%
Experimental Autoimmune Encephalomyelitis
50%
Interferon-α (IFN-α)
25%
Receptor Knockout
25%
Wild Mice
25%
G Protein-coupled Receptor
25%
Interleukin-17 (IL-17)
25%
Disease Pathogenesis
25%
Clinical Disease
25%
Neuropathology
25%
Demyelinating Diseases
25%
Splenocytes
25%
Autoimmune
25%
Ancillary
25%
Pharmacological Targeting
25%
Blood-brain Barrier Permeability
25%
Combinatorial Targeting
25%
Central Nervous System Demyelinating Diseases
25%
Chronic Inflammatory Demyelinating
25%
Antipathogenic Activity
25%
Histamine Receptors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Histamine
100%
Multiple Sclerosis
100%
Inflammatory Disease
100%
Tritium
100%
Histamine H4 Receptor
100%
Diseases
100%
Disease Course
50%
Experimental Autoimmune Encephalomyelitis
50%
Wild Type Mouse
25%
Receptor
25%
Interferon
25%
Demyelinating Disease
25%
G Protein Coupled Receptor
25%
Interleukin 17
25%
Histamine Receptor
25%
Blood-Brain Barrier
25%
Immunology and Microbiology
Inflammatory Disorder
100%
Central Nervous System
100%
Multiple Sclerosis
100%
Histamine
100%
Experimental Autoimmune Encephalomyelitis
50%
Wild Type
25%
interferon
25%
Wild Type Mouse
25%
Blood Brain Barrier
25%
Splenocyte
25%
Clinically Isolated Syndrome
25%
Interleukin 17
25%